Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): multiple myeloma (version 2.2019). 2018.
http://www.nccn.org
. Accessed 7 Feb 2019.
2. Fonseca R, Abouzaid S, Bonafede M, et al. Trends in overall survival and costs of multiple myeloma, 2000–2014. Leukemia. 2017;31(9):1915–21.
3. Moreau P, San Miguel J, Sonneveld P, et al. Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(Suppl 6):52–61.
4. Willenbacher E, Balog A, Willenbacher W. Short overview on the current standard of treatment in newly diagnosed multiple myeloma. Memo. 2018;11(1):59–64.
5. Chari A, Mehra M, Slavcev M, et al. Evaluation and comparison of characteristics and outcomes among frontline multiple myeloma (FLMM) patients with and without stem cell transplant treatment [abstract no. 4738]. In: 60th American Society of Hematology Annual Meeting and Exposition. 2018.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献